American Healthcare REIT (AHR) Shares Soar 1.44% on Strong Q1 Earnings

American Healthcare (AHR) shares surged to a record high today, with an intraday gain of 1.44%.

The strategy of buying American Healthcare (AHR) shares after they reached a high and holding for one week yielded a 11.98% return over the past five years, slightly underperforming the benchmark at 6.58%. The maximum drawdown was -5.73%, with a Sharpe ratio of 1.00 and a volatility of 9.88%. The CAGR was 9.91%.

American Healthcare REIT Inc (AHR) reported robust Q1 2025 performance with significant NOI growth and a promising acquisition pipeline. This strong financial performance has bolstered investor confidence in the company's future prospects.

Citizens JMP has increased its price target for American Healthcare REIT (AHR) from $35 to $40, maintaining an Outperform rating. This upgrade reflects the analysts' optimism about the company's growth potential and strategic initiatives.

AHR is investing in a $300 million growth pipeline with a focus on its SHOP segment, reflecting strategic expansion plans. This investment is aimed at enhancing the company's market position and driving long-term growth.

The company’s integrated senior campuses showed an average occupancy rate increase from 85.6% in Q1 2024 to 88.5% in Q1 2025, which positively impacts its financial outlook. This increase in occupancy rates indicates strong demand for the company's services and a healthy operational environment.

AHR announced increased guidance for the full year 2025, highlighting strong financial performance and future expansion capability. This revised guidance underscores the company's confidence in its ability to deliver sustained growth and profitability.